EUVIMEDEUVIMED entdecken
Crossref

Actual Use of Budesonide Enteric-Coated Capsules for Crohn’s Disease in Japan: Analysis of Health Insurance Big Data

Keiji Yagisawa, Atsuhito Kubota, Shungo Imai, Shunsuke Nashimoto, Yuki Sato, Hitoshi Kashiwagi, Atsuo Maemoto, Mitsuru Sugawara, Yoh Takekuma

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b24-00435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Keiji Yagisawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Life Science, Hokkaido University, Kita 10, Nishi 8, Kita-ku, Sapporo 060-0810, Japan. Hauptthemen laut MEDLINE: Crohn Disease, Budesonide, Anti-Inflammatory Agents. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseBudesonideAnti-Inflammatory AgentsHumansJapanFemaleMaleAdultMiddle AgedBig DataInsurance, HealthCapsulesYoung AdultDatabases, FactualTablets, Enteric-CoatedAged

Stichwörter der Autor:innen

Crohn’s diseasebudesonideclaims databaseinflammatory bowel disease

Substanzen

BudesonideCapsulesTablets, Enteric-CoatedAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Graduate School of Life Science, Hokkaido University, Kita 10, Nishi 8, Kita-ku, Sapporo 060-0810, Japan.
  • Department of Pharmacy, Sapporo-Higashi Tokushukai Hospital, 3-1 Kita 33, Higashi 14, Higashi-ku, Sapporo 065-0033, Japan.
  • School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 1757 Kanazawa, Tobetsu-cho, Ishikari-gun, Hokkaido 061-0293, Japan.
  • Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan.
  • Inflammatory Bowel Disease Center, Sapporo Higashi Tokushukai Hospital, Kita 33, Higashi 14, Higashi-ku, Sapporo 065-0033, Japan.

Zitieren

APA

Yagisawa, K., Kubota, A., Imai, S., Nashimoto, S., Sato, Y., Kashiwagi, H., Maemoto, A., Sugawara, M., & Takekuma, Y. (2025). Actual Use of Budesonide Enteric-Coated Capsules for Crohn’s Disease in Japan: Analysis of Health Insurance Big Data. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00435

Vancouver

Yagisawa K, Kubota A, Imai S, Nashimoto S, Sato Y, Kashiwagi H, et al. Actual Use of Budesonide Enteric-Coated Capsules for Crohn’s Disease in Japan: Analysis of Health Insurance Big Data. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00435

BibTeX
@article{Yagisawa2025,
  author = {Yagisawa, Keiji and Kubota, Atsuhito and Imai, Shungo and Nashimoto, Shunsuke and Sato, Yuki and Kashiwagi, Hitoshi and Maemoto, Atsuo and Sugawara, Mitsuru and Takekuma, Yoh},
  title = {Actual Use of Budesonide Enteric-Coated Capsules for Crohn’s Disease in Japan: Analysis of Health Insurance Big Data},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b24-00435}
}
Kostenlos starten →